<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJNeph</journal-id><journal-title-group><journal-title>Open Journal of Nephrology</journal-title></journal-title-group><issn pub-type="epub">2164-2842</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojneph.2020.104033</article-id><article-id pub-id-type="publisher-id">OJNeph-104277</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  First Emergency Hemodialysis Session at the Nephrology Department of the Teaching Hospital of Yopougon: About 146 Cases
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Konan</surname><given-names>Serge Didier</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kissou</surname><given-names>Pegdebamba François</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Guei</surname><given-names>Monlet Cyr</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Diopoh</surname><given-names>Sery Patrick</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aka</surname><given-names>Jean Astrid</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yao</surname><given-names>Kouamé Hubert</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of Nephrology, CHU Yopougon, Abidjan, Ivory Coast</addr-line></aff><aff id="aff1"><addr-line>Nephrology-Internal Medicine Department D, CHU Treichville, Abidjan, Ivory Coast</addr-line></aff><pub-date pub-type="epub"><day>15</day><month>10</month><year>2020</year></pub-date><volume>10</volume><issue>04</issue><fpage>338</fpage><lpage>347</lpage><history><date date-type="received"><day>14,</day>	<month>October</month>	<year>2020</year></date><date date-type="rev-recd"><day>20,</day>	<month>November</month>	<year>2020</year>	</date><date date-type="accepted"><day>23,</day>	<month>November</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Context: Due to the late referral of the pads to the nephrologist and the lack of medical follow-up, many patients are admitted with complications from kidney disease requiring the urgent start of hemodialysis sessions. 
  Purpose: Study the profile of emergency hemodialysis patients in order to ease their management. 
  Methods: This was a retrospective, descriptive and analytical study carried out at the Nephrology Department of the Teaching Hospital of Yopougon from January 1st to December 31st, 2016. This study included all patients who had received a first session of hemodialysis in an emergency context. 
  Results: We collected 146 patients with an average age of 39.80 &#177; 14.55 years and a sex ratio of 0.6 for men. Before admission, patients were known as hypertensives (63.9%), followed by CKD (23.9%) and HIV-infected (8.2%). The main clinical signs were hypertension (64.3%), edema (44.5%) and coma (30.1%). Anemia was observed in 97.2% of cases and it was less than 8 g/dl in 57.5%. Kidney failure was chronic in 75.3% and acute in 24.6%. Chronic nephropathies were glomerular (54.1%), vascular (20.5%). The main indications for hemodialysis were encephalopathy (33.5%), severe uremia (28%), acute pulmonary edema (19.8%), persistent anuria (11.6%) and hyperkalemia (5.4%). The vascular approach was a catheter in 97.2% (femoral site in 53.4% and jugular in 43.8% and arteriovenous fistula in 2.7%). Death was observed in 17.8%. In univariate analysis, age &gt; 65 years (p = 0.04), coma (p = 0.004) and acute kidney failure (p = 0.02) were associated with the risk of death, and in multivariate analysis, only coma (p = 0.024, OR = 5.88) seemed to be associated with mortality risk for our patients. 
  Conclusion: Hemodialysis in an emergency situation is a common practice in the Teaching Hospital of Yopougon and mainly concerns patients with CKD.
 
</p></abstract><kwd-group><kwd>Kidney Failure</kwd><kwd> Hemodialysis</kwd><kwd> Emergency</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Kidney pathology constitutes a major public health problem in the world due to its frequency, high mortality rate and the costs of its treatment [<xref ref-type="bibr" rid="scirp.104277-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.104277-ref2">2</xref>].</p><p>Nephrological emergencies are not so frequent but they most often deal with management problems [<xref ref-type="bibr" rid="scirp.104277-ref3">3</xref>]. Their treatment often calls for hemodialysis, which can supplement the functions of cleaning uremic toxins and fluid and electrolytes balance, thereby improving their prognosis [<xref ref-type="bibr" rid="scirp.104277-ref4">4</xref>]. Despite these therapeutic advances made over the past 50 years, the mortality of patients with kidney impairment requiring emergency dialysis remains high [<xref ref-type="bibr" rid="scirp.104277-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.104277-ref6">6</xref>].</p><p>In 2010, replacement therapy ensured the survival of nearly 3 million patients worldwide, 78% of whom were on dialysis [<xref ref-type="bibr" rid="scirp.104277-ref7">7</xref>]. The incidence of acute kidney injury requiring hemodialysis is increasing and associated with high mortality [<xref ref-type="bibr" rid="scirp.104277-ref8">8</xref>].</p><p>In France, the 2011 REIN report estimated the incidence of dialysis patients at 144/million inhabitants [<xref ref-type="bibr" rid="scirp.104277-ref9">9</xref>]. In the United States of America, the rate of acute renal damage requiring extrarenal purification increased from 3227/million peope/year in 1996 to 5224/million people/year in 2003. In Canada, it increased from 0.8% to 3% from 1996 to 2010 [<xref ref-type="bibr" rid="scirp.104277-ref6">6</xref>].</p><p>In Senegal in 2016, a hospital study noted that 84.7% of patients in a hemodialysis center had received emergency sessions and that 34.2% of these patients had acute renal failure [<xref ref-type="bibr" rid="scirp.104277-ref10">10</xref>].</p><p>Data on emergency dialysis patients are scarce in our practice setting. Our work aims to study the profile of patients who have benefited from a first emergency hemodialysis session in order to facilitate decision-making for their management.</p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Type and Scope of the Study</title><p>Our study took place in the Nephrology department of the Teaching Hospital of Yopougon in Abidjan, Ivory Coast. This was a retrospective, descriptive and analytical study that took place over a period going from January 1st to December 31st, 2016.</p><p>This department includes an inpatient unit with a capacity of 20 beds, an outpatient unit, a hemodialysis unit with 07 generators, one of which is broken.</p></sec><sec id="s2_2"><title>2.2. Study Population</title><p>We included all patients who received a first dialysis session in an emergency setting during the study period. Dialysis patients admitted urgently but who were not having their first dialysis session at that moment and those whose medical records were incomplete for the parameters sought were not included.</p></sec><sec id="s2_3"><title>2.3. Variables</title><p>For each patient included, the following data were collected using a standardized survey sheet:</p><p>- Sociodemographic data: age, sex, profession, level of education;</p><p>- Co-morbidities: hypertension, diabetes, HIV, CKD, drug abuse (alcohol, tobacco, NSAIDs, PCI, use of traditional products);</p><p>- Clinical data: the department of origin, reasons for hospitalization, state of consciousness, state of hydration, blood pressure; edema, acute lung edema, urine output;</p><p>- Blood biological data: hemoglobin level, number of white blood cells and platelets, creatinine, urea, sodium, potassium, calcium, CRP;</p><p>- The type of renal failure: acute kidney injury (AKI) or chronic kidney desease (CKD) with the different mechanisms;</p><p>- Therapeutic data: hemodialysis with the indication of the session, the vascular access and the number of sessions, other treatments;</p><p>- Evolutionary data: duration of hospitalization, recovery or not of renal function, death.</p></sec><sec id="s2_4"><title>2.4. Definition of Operational Terms</title><p>Renal function was assessed using the MDRD formula. Renal failure was defined by a glomerular filtration rate (GFR) of less than 60 ml/min for 1.73 m<sup>2</sup>. The chronic nature was defined by the length of renal failure (more than 3 months) and/or normochromium are generative normocytic anemia and/or hypocalcemia and/or associated renal atrophy. The IRC was said to be terminal (or stage 5) when it was less than 15 ml/min.</p><p>In the absence of renal biopsies, the etiological research of renal failure was based on a set of clinical and paraclinical arguments. Thus, chronic glomerular nephropathy (CGN) has been evoked by the presence of proteinuria greater than 2 g/d or proteinuria associated with hematuria. Chronic vascular nephropathy nephroangiosclerosis type was retained due to the existence of hypertension, low flow proteinuria (&lt;1 g/d), and renal failure associated with signs of hypertensive retinopathy in the fundus. Nephropathy associated with HIV has been evoked in the presence of massive proteinuria without arterial hypertension or hematuria, in any patient infected with HIV and of recent discovery (&lt;3 months), diabetic nephropathy in the presence of proteinuria greater than 500 mg/24 hours associated with diabetic retinopathy on fundus examination, chronic tubulointerstitial nephropathy (CTIN) before the existence of proteinuria (&lt;1 g/24 h) associated with leukocyturia without germ and kidneys with irregular and dented outlines.</p><p>Functional acute kidney failure (AKI) was retained in the presence of renal hypoperfusion factor (diarrhea, vomiting, low cardiac output) or in front of signs of extracellular dehydration. Obstructive AKI was retained in the presence of bilateral dilation of the pyelocalicular cavities. Organic AKI was retained after exclusion of functional and obstructive AKIs.</p><p>Arterial hypertension was defined by the observation of blood pressure levels greater than or equal to 140 mmHg systolic-wise and/or greater than or equal to 90 mmHg diastolic-wise. The arterial pressure was divided into three grades: grade 1 or mild hypertension between 140 and 159 mmHg systolic-wise and between 90 and 99 mmHg diastolic-wise; grade 2 or mean hypertension between 160 and 179 mmHg systolic-wise and between 100 and 109 mmHg diastolic-wise; grade 3 or severe hypertension for blood pressure greater than or equal to 180 mmHg systolic-wise and greater than or equal to 110 mmHg diastolic-wise.</p><p>Anemia was defined as a hemoglobin level less than 12 g/dl. It was said to be severe when the hemoglobin level was less than 8 g/dl and moderate between 8 and 12 g/dl.</p></sec><sec id="s2_5"><title>2.5. Statistical Analysis</title><p>The data were entered using Excel software and analyzed using SPSS software in version 22. The statistical test used was the exact chi-square test with a significance level p &lt; 0.05.</p></sec></sec><sec id="s3"><title>3. Results</title><p>During the study period, 213 patients received emergency dialysis in the ward. Of these, 146 met the inclusion criteria. The patients’ medium age was 39.80 &#177; 14.55 years with the extremes of 13 and 85 years. The age group of [35 – 65] years was the most represented with 54.7%. We observed 59.5% of male subjects and 40.4% of female subjects.</p><p>Patients’ medical history was dominated by hypertension (63.9%), CKD (23.9%) and HIV-infection (8.2%). The main clinical signs were hypertensive surge (64.3%), edema (44.5%) and coma (30.1%) (<xref ref-type="table" rid="table1">Table 1</xref>). This hypertension was grade 3 in 42.5% of cases.</p><p>Anemia was observed in 97.2% of cases and it was less than 8 g/dl in 57.5%. The other laboratory abnormalities were hyperkalemia (28%), hypocalcemia (70.1%), hyponatremia (68.7%) and elevated C Reactive Protein (CRP) (93.3%) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Kidney failure was chronic in 75.3% and acute in 24.6%. Chronic nephropathies were glomerular (54.1%), vascular (20.5%).</p><p>The main indications for hemodialysis were encephalopathy (33.5%), severe uremia (28%), acute lung edema (19.8%), persistent anuria (11.6%) and hyperkalaemia (5.4%).</p><p>The vascular access was a catheter in 97.2% (femoral site in 53.4% and jugular in 43.8%) and an arteriovenous fistula in 2.7%.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> General characteristics of the patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Total (n = 146)</th><th align="center" valign="middle" >Deceased (n = 26)</th><th align="center" valign="middle" >alive (n = 120)</th><th align="center" valign="middle" >p</th><th align="center" valign="middle" >OR (IC = 95%)</th></tr></thead><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >59.6% (87/146)</td><td align="center" valign="middle" >61.5% (16/26)</td><td align="center" valign="middle" >59.1% (71/120)</td><td align="center" valign="middle" >0.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >40.4% (59/146)</td><td align="center" valign="middle" >38.6% (10/26)</td><td align="center" valign="middle" >40.8% (49/120)</td><td align="center" valign="middle" >0.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;35</td><td align="center" valign="middle" >39.7% (58/146)</td><td align="center" valign="middle" >23.0% (6/26)</td><td align="center" valign="middle" >43.3% (52/120)</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >[35-65]</td><td align="center" valign="middle" >54.7% (80/146)</td><td align="center" valign="middle" >61.5% (16/26)</td><td align="center" valign="middle" >53.3% (64/120)</td><td align="center" valign="middle" >0.4</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≥65</td><td align="center" valign="middle" >5.4% (8/146)</td><td align="center" valign="middle" >15.3% (4/26)</td><td align="center" valign="middle" >3.3% (4/120)</td><td align="center" valign="middle" >0.04</td><td align="center" valign="middle" >4.18 (1.04 - 16.8)</td></tr><tr><td align="center" valign="middle" >Comorbidities</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >63.6% (93/146)</td><td align="center" valign="middle" >53.8% (14/26)</td><td align="center" valign="middle" >65.8% (79/120)</td><td align="center" valign="middle" >0.24</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CKD</td><td align="center" valign="middle" >23.9% (35/146)</td><td align="center" valign="middle" >15.3% (4/26)</td><td align="center" valign="middle" >25.8% (31/120)</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >HIV</td><td align="center" valign="middle" >8.2% (12/146)</td><td align="center" valign="middle" >38% (1/26)</td><td align="center" valign="middle" >9.1% (11/120)</td><td align="center" valign="middle" >0.3</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Clinical Signs</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >64.3% (94/120)</td><td align="center" valign="middle" >46.1% (12/26)</td><td align="center" valign="middle" >68.3% (82/120)</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Edema</td><td align="center" valign="middle" >44.5% (65/146)</td><td align="center" valign="middle" >42.3% (11/26)</td><td align="center" valign="middle" >45.% (54/120)</td><td align="center" valign="middle" >0.3</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Coma</td><td align="center" valign="middle" >30.1% (44/146)</td><td align="center" valign="middle" >57.6% (15/26)</td><td align="center" valign="middle" >24.1% (29/120)</td><td align="center" valign="middle" >0.008</td><td align="center" valign="middle" >7.14 (1.6 - 30.8)</td></tr><tr><td align="center" valign="middle" >Dehydration</td><td align="center" valign="middle" >12.3% (18/146)</td><td align="center" valign="middle" >23.1% (6/26)</td><td align="center" valign="middle" >10% (12/120)</td><td align="center" valign="middle" >0.06</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Lung edema</td><td align="center" valign="middle" >6.8% (10/146)</td><td align="center" valign="middle" >3.8% (1/26)</td><td align="center" valign="middle" >7.5% (9/120)</td><td align="center" valign="middle" >0.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Blood pressure grade</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.9% (14/94)</td><td align="center" valign="middle" >19.2% (5/26)</td><td align="center" valign="middle" >13.2% (9/68)</td><td align="center" valign="middle" >0.06</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >42.5% (40/94)</td><td align="center" valign="middle" >11.5% (3/26)</td><td align="center" valign="middle" >54.4% (37/68)</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" >0.29 (0.08 - 1.03)</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >42.5% (40/94)</td><td align="center" valign="middle" >15.3% (4/26)</td><td align="center" valign="middle" >52.9% (36/68)</td><td align="center" valign="middle" >0.13</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Biology</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Elevated CRP</td><td align="center" valign="middle" >93.3% (127/136)</td><td align="center" valign="middle" >92.3% (24/26)</td><td align="center" valign="middle" >85.8% (103/120)</td><td align="center" valign="middle" >0.7</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hypocalcemia</td><td align="center" valign="middle" >70.1% (54/146)</td><td align="center" valign="middle" >26.9% (7/26)</td><td align="center" valign="middle" >39.1% (47/120)</td><td align="center" valign="middle" >0.6</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hyponatremia</td><td align="center" valign="middle" >68.7 (99/144)</td><td align="center" valign="middle" >65.3% (17/26)</td><td align="center" valign="middle" >39.1% (47/120)</td><td align="center" valign="middle" >0.51</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hb &lt; 8</td><td align="center" valign="middle" >57.5% (84/146)</td><td align="center" valign="middle" >50% (13/26)</td><td align="center" valign="middle" >59.1% (71/120)</td><td align="center" valign="middle" >0.61</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hyperkaliemia</td><td align="center" valign="middle" >28.1% (41/146)</td><td align="center" valign="middle" >42.3% (11/26)</td><td align="center" valign="middle" >25% (30/120)</td><td align="center" valign="middle" >0.06</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Acute Kidney Injury</td><td align="center" valign="middle" >24.6% (36/146)</td><td align="center" valign="middle" >42.3% (11/26)</td><td align="center" valign="middle" >20.8% (25/120)</td><td align="center" valign="middle" >0.02</td><td align="center" valign="middle" >2.7 (1.1 - 6.8)</td></tr></tbody></table></table-wrap><p>The outcome was favorable in 82.2% and death observed in 17.8%. Kidney function stabilized in 71.9% and normalized in 10.2%. In univariate analysis, age &gt; 65 years (p = 0.04), coma (p = 0.004) and acute acute kidney injury (p = 0.02) were associated with the risk of death (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>In multivariate analysis, only coma seemed to be associated with the risk of mortality in our patients (<xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Risk factor for death after multivariate logistic regression analysis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >P</th><th align="center" valign="middle" >OR</th><th align="center" valign="middle" >IC (95%)</th></tr></thead><tr><td align="center" valign="middle" >Age &gt; 65 ans</td><td align="center" valign="middle" >0.2</td><td align="center" valign="middle" >0.4</td><td align="center" valign="middle" >0.07 - 1.8</td></tr><tr><td align="center" valign="middle" >AKI</td><td align="center" valign="middle" >0.2</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >0.18 - 13</td></tr><tr><td align="center" valign="middle" >Coma</td><td align="center" valign="middle" >0.02</td><td align="center" valign="middle" >5.8</td><td align="center" valign="middle" >1.2 - 33.3</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>This work describes the profile of patients undergoing their first hemodialysis session in an emergency situation. The majority of these were young adults. Our results are similar to those found by Yaya Kane et al. in Senegal [<xref ref-type="bibr" rid="scirp.104277-ref10">10</xref>] who noted an average age of 41.3 years. On the other hand, our patients seemed younger than those of Dali Youcef et al. in Algeria [<xref ref-type="bibr" rid="scirp.104277-ref11">11</xref>] who had found a medium age of 57.8 &#177; 16 years. This difference could be explained by the difference in life expectancy which seems to be higher in Maghreb.</p><p>The male predominance observed in our work is found in all the African series [<xref ref-type="bibr" rid="scirp.104277-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.104277-ref12">12</xref>]. This could be explained by the predominance of Kidney disease in men.</p><p>The comorbidities were dominated by hypertension found in one out of ten patients, followed by HIV infection. Fayrouz Zemed et al observed hypertension in 46% of cases in Morocco in 2017 [<xref ref-type="bibr" rid="scirp.104277-ref13">13</xref>]. In our context, hypertension followed by HIV infection is the two main risk factors for chronic renal failure [<xref ref-type="bibr" rid="scirp.104277-ref14">14</xref>].</p><p>Almost one in four patients (24%) had a known CKD. The fact that the latter begin their hemodialysis sessions under emergency conditions could be explained by the high cost of treatment and/or the availability of centers. This would be added the refusal to accept the disease in some cases.</p><p>The clinical signs vary according to the departments in which the studies are carried out. Thus, the hypertensive surge observed in six out of ten patients in our study is a common situation in nephrology. In intensive care settings, neurological disorders are frequent and may affect eight out of ten patients as observed by Fayrouz Zemed et al. [<xref ref-type="bibr" rid="scirp.104277-ref12">12</xref>].</p><p>CKD was predominant and found in over two-thirds of our patients. In Algeria, Dali Youcef [<xref ref-type="bibr" rid="scirp.104277-ref11">11</xref>] noted a predominance of AKIs with 65%. This difference could be explained by the difficulty of access to hemodialysis by patients in our context. This difficulty could be attributable not only to the high cost of dialysis in private centers but also to the availability of public centers, which remains limited.</p><p>The probable etiologies of CKD were dominated by CGN with 70.91% of cases. Our results corroborate with those of the numerous studies that show a high proportion of CGN in the aetiologies of especially in our context [<xref ref-type="bibr" rid="scirp.104277-ref14">14</xref>].</p><p>In our study, the indications for hemodialysis were dominated by uremic encephalopathy and severe uremia. Other authors [<xref ref-type="bibr" rid="scirp.104277-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.104277-ref15">15</xref>] have reported hyperkalemia and anuria as the main indications for emergency dialysis. This difference could be explained by the predominance of CKD cases in our study versus a predominance of AKIs in these studies.</p><p>The catheter is the main vascular access for emergency hemodialysis, as reported by various authors [<xref ref-type="bibr" rid="scirp.104277-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.104277-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.104277-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.104277-ref15">15</xref>]. The installation site varies according to the habits of the services. Thus, the femoral catheter was the most used followed by the jugular catheter in our patients. Dali Youcef et al. [<xref ref-type="bibr" rid="scirp.104277-ref11">11</xref>] reported the femoral catheter in 72.5%, the site in 15% and the AVF in 12.5%.</p><p>The mortality of 17.80% in our series was lower than that observed in the Moroccan series, respectively 32.2% [<xref ref-type="bibr" rid="scirp.104277-ref13">13</xref>] and 70% [<xref ref-type="bibr" rid="scirp.104277-ref15">15</xref>].</p><p>The high proportion of CKD cases in our work and the comorbidities of the patients could explain this difference. When analyzing the cases of AKI in our patients, mortality was in the order of 30.55%. In the sub-Saharan African series, mortality varies between 34.1% [<xref ref-type="bibr" rid="scirp.104277-ref16">16</xref>] and 42.1% [<xref ref-type="bibr" rid="scirp.104277-ref10">10</xref>] in the event of AKI. Globally, AKI-related mortality can reach 50% according to some meta-analyzes and this mortality could be higher in the absence of hemodialysis [<xref ref-type="bibr" rid="scirp.104277-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.104277-ref17">17</xref>].</p><p>On univariate analysis, age &gt; 65 years, coma, and AKI appeared to be risk factors for mortality. But in multivariate analysis, only coma was significantly linked to death. Talbi Sofia et al. [<xref ref-type="bibr" rid="scirp.104277-ref13">13</xref>] reported that hyperkalaemia was significantly associated with death in emergency hemodialysis AKIs. In the study by Suter Mendon&#231;a et al. [<xref ref-type="bibr" rid="scirp.104277-ref18">18</xref>], age ≥ 65 years was a risk factor for death in AKI.</p></sec><sec id="s5"><title>5. Conclusions</title><p>Hemodialysis in an emergency is a common practice at the Yopougon University Hospital. Our patients were predominantly young with a predominance of men. Almost all of the patients were hospitalized for various reasons dominated by neurological disorders and edema. The main physical signs were hypertension, edema and coma. Apart from very high urea levels and serum creatinine, anemia and inflammatory syndrome were found in almost all of our patients.</p><p>CKD cases were predominant and found in three out of four patients with CGN as the main initial nephropathy. Uremic encephalopathy dominated the indications for the hemodialysis session. The femoral catheter was the most widely used vascular access.</p><p>Mortality was 17.80% and higher in AKI cases. Coma seems to be a factor of poor prognosis.</p><p>It turns out that emergency hemodialysis is a critical situation especially for AKI cases. It is therefore imperative to be prompt in performing hemodialysis.</p></sec><sec id="s6"><title>Limitations of the Study</title><p>Our study had limitations due to its retrospective nature. The information sought in the clinical records of patients was sometimes not complete.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Didier, K.S., Fran&#231;ois, K.P., Cyr, G.M., Patrick, D.S., Astrid, A.J. and Hubert, Y.K. (2020) First Emergency Hemodialysis Session at the Nephrology Department of the Teaching Hospital of Yopougon: About 146 Cases. Open Journal of Nephrology, 10, 338-347. https://doi.org/10.4236/ojneph.2020.104033</p></sec><sec id="s9"><title>Appendix</title>Standardized Survey Sheet<p>Hospitalization file number: …………………………………………</p><p>1) DEMOGRAPHIC DATA</p><p>Age: …. Years Sex: M □ F □</p><p>Level of study: primary □ secondary □ University□ lliterate □</p><p>Profession: ……………</p><p>2) CLINICS</p><p>Reason for admission ……………………………………………………………….</p><p>Antecedents</p><p>Hypertension: Yes □ No □</p><p>Diabetes: Yes □ No □; CKD: Yes □ No □; HIV: Yes □ No □</p><p>Taking toxic substances: Tobacco: Yes □ No □; alcohol: Yes □ No □;</p><p>Traditional medicines: Yes □ No □; NSAIDs: Yes □ No □,</p><p>Exams</p><p>State of consciousness: …………… .. State of hydration: …………………………</p><p>Blood pressure: ………….mmHg</p><p>3) BLOOD BIOLOGY</p><p>WBC ……. /mm<sup>3</sup>, Hb: …… g/dL, Platelets: …. &#215;10<sup>3</sup>/mm<sup>3</sup>, Urea ……… g/L Creatinine …..mg/L, CRP: …..mg/L, Na<sup>+</sup>: ……MEq/L, Ca2<sup>+</sup>: ….mg/L, K<sup>+</sup>: …..mEq/L</p><p>4) DIAGNOSTIC</p><p>Acute Kidney Injury: Yes □ No □ if yes type: ………………………...</p><p>Chronic Kidney Desease: Yes □ No □ if yes type: ……………………</p><p>5) TREATMENT</p><p>Hemodialysis</p><p>HD indication: ………………………………………………………</p><p>Vascular access: ………………………………………………………….…</p><p>Number of sessions: …………………………………………………………….</p><p>Other treatments</p><p>Blood Transfusion: Yes □ No □</p><p>Antibiotic therapy: Yes □ No □</p><p>6) EVOLUTION</p><p>Healing: Yes □ No □</p><p>Stabilization: Yes □ No □</p><p>Death: Yes □ No □ if Yes cause: …………………………………</p><p>Duration of hospitalization: ………………………………………</p></sec></body><back><ref-list><title>References</title><ref id="scirp.104277-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Bello, A.K., Levin, A., Tonelli, M., Okpechi, I.G., Feehally, J., Harris, D., et al. (2017) Assessment of Global Kidney Health Care Status. JAMA, 317, 1864-1881. https://doi.org/10.1001/jama.2017.4046</mixed-citation></ref><ref id="scirp.104277-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Fouda, H., Ashuntantang, G., Kaze, F. and Halle, M.-P. (2017) Survival among Chronic Hemodialysed Patient in Cameroon. Pan African Medical Journal, 26, 97.</mixed-citation></ref><ref id="scirp.104277-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Suisse</surname><given-names> D. </given-names></name>,<etal>et al</etal>. (<year>2016</year>)<article-title>Quand appeler le néphrologue aux urgences</article-title><source> Revue Médicale Suisse</source><volume> 12</volume>,<fpage> 398</fpage>-<lpage>403</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.104277-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">James, M.T., Heerspink, H.J.L., Pollock, C.A. and Stevens, P.E. (2018) Improving the Prognosis of Patients with Severely Decreased Glomerular Filtration Rate (CKD G4+): Conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 93, 1281-1292.</mixed-citation></ref><ref id="scirp.104277-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Thervet, E. (2017) Traité de Néphrologie. Editions Lavoisier Médecine Sciences.</mixed-citation></ref><ref id="scirp.104277-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Town, C., Mehta, R.L., Cerdá, J., Burdmann, E.A., Tonelli, M., García-garcía, G., et al. (2015) Congress International Society of Nephrology’s 0by25 Initiative for Acute Kidney Injury (Zero Preventable Deaths by 2025): A Human Rights Case for Nephrology. The Lancet, 385, 2616-2643. https://doi.org/10.1016/S0140-6736(15)60126-X</mixed-citation></ref><ref id="scirp.104277-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H.M., Okpechi, I., et al. (2013) Worldwide Access to Treatment for End-Stage Kidney Disease. The Lancet, 385, 1975-1982. https://doi.org/10.1016/S0140-6736(14)61601-9</mixed-citation></ref><ref id="scirp.104277-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Kolhe, N.V., Muirhead, A.W., Wilkes, S.R., Fluck, R.J. and Taal, M.W. (2015) National Trends in Acute Kidney Injury Requiring Dialysis in England between 1998 and 2013. Kidney International, 88, 1161-1169. https://doi.org/10.1038/ki.2015.234</mixed-citation></ref><ref id="scirp.104277-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Couchoud, C., Lassalle, M. and Jacquelinet, C. (2013) Rapport Rein 2011—Synthèse. Néphrologie Thérapeutique, 9, S3-S6. https://doi.org/10.1016/S1769-7255(13)70036-1</mixed-citation></ref><ref id="scirp.104277-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Yaya, K., De, S., Aristide, H., Dantec, L. and Sénégal, D. (2016) Décentralisation De La Dialyse Au Sénégal: Expérience d’un an du centre de Tambacounda à l’Est du Pays. European Scientific Journal, 12, 164-173. https://doi.org/10.19044/esj.2016.v12n36p164</mixed-citation></ref><ref id="scirp.104277-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Dali Youcef, H.S. (2016) La Dialyse en Urgence. Thèse Médecine 2017. Université Abou Bekr Belkaid Tlmen, Algerie.</mixed-citation></ref><ref id="scirp.104277-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Farouz, Z. (2017) Epuration extrarénale en réanimation. Thèse de médecine, Université Cadi Ayyad Marrakech (Maroc).</mixed-citation></ref><ref id="scirp.104277-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Talbi, S. (2011) Hémodialyse en situation d’urgence (à propos de 207 cas). Thèse de Médecine, Université Sidi Mohammed Ben Abdellah Fès (Maro).</mixed-citation></ref><ref id="scirp.104277-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Yao, H.K., Konan, S.D., Sanogo, S., Diopoh, S.P. and Diallo, A.D. (2018) Prevalence and Risk Factors of Chronic Kidney Disease in Cote D’Ivoire: An Analytic Study Conducted in the Department of Internal Medicine. Saudi Journal of Kidney Diseases and Transplantation, 29, 153-159. https://doi.org/10.4103/1319-2442.225201</mixed-citation></ref><ref id="scirp.104277-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Bouda, R. (2016) Epuration extrarénale en réanimation (à propos de 40 cas). Thèse de médecine, Université Cadi Ayyad Marrakech (Maroc).</mixed-citation></ref><ref id="scirp.104277-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Adu, D., Okyere, P., Doima, V., Malekole, M. and Osafo, C. (2016) Community-Acquired Acute Kidney Injury in Adults in Africa. Clinical Nephrology, 86, S48-S52. https://doi.org/10.5414/CNP86S121</mixed-citation></ref><ref id="scirp.104277-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Igiraneza, G., Ndayishimiye, B., Nkeshimana, M., Dusabejambo, V. and Ogbuagu, O. (2018) Clinical Profile and Outcome of Patients with Acute Kidney Injury Requiring Hemodialysis: Two Years’ Experience at a Tertiary Hospital in Rwanda. BioMed Research International, 2018, Article ID: 1716420. https://doi.org/10.1155/2018/1716420</mixed-citation></ref><ref id="scirp.104277-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Suter, P.M., Moreno, R., Dearden, N.M., Antonelli, M., Takala, J., St, A., et al. (2000) Acute Renal Failure in the ICU: Risk Factors and Outcome Evaluated by the SOFA Score. Intensive Care Medicine, 26, 915-921. https://doi.org/10.1007/s001340051281</mixed-citation></ref></ref-list></back></article>